Download PDFPDF
Extended report
Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Results of remission targeted therapy last longer than a year
    • Vappu M. Rantalaiho, MD
    • Other Contributors:
      • Markku Korpela, Kari Puolakka, Marjatta Leirisalo-Repo, Pekka Hannonen, Hannu Kautiainen and Timo Mottonen

    Dear Editor,

    Gorter and collagues (1) cover elegantly the literature on the efficacy of systemic glucocorticoids (GCs) in rheumatoid arthritis (RA). Nevertheless, we would like to draw attention to an error concerning the results of the FIN-RACo Trial (2). The authors are correct when presenting the treatment strategies used in the FIN-RACo Trial and stating the implausibility of mere systemic GCs explaining the...

    Show More
    Conflict of Interest:
    None declared.